|
|
AGENDA
National CME Audioconference: Dealing with Transparency - How Drug and Device Companies are Operationalizing Disclosure of Educational Grants
- Tuesday, May 27, 2008
1:00 pm - 2:30 pm (Eastern)
12:00 pm - 1:30 pm (Central)
11:00 am - 12:30 pm (Mountain)
10:00 am - 11:30 am (Pacific)
|
|
|
The tentative Audioconference agenda is set forth in Eastern Daylight Time below:
|
|
1:00 pm |
Welcome and Introductory Remarks
John Kamp, JD, PhD
|
1:05 pm |
Update on Senator Charles Grassley's Inquiry into Drug and Device Disclosure of Education Grants
Christopher J. Armstrong, Esq.
Link resources for "From MCE Funding to Physician Payments: a Senate Update" by Christopher Armstrong
June 2005, Senators Grassley and Baucus ask industry for information about grant money awarded to promote particular medicines:
April 2007, Committee Staff Report on use of education grants by drug companies:
February 2008, Senator Grassley asks drug and device companies to disclose financial relationships with the medical community:
April 2008, Senator Grassley receives industry responses:
Baxter:
Medtronic:
Boston Scientific:
Merck:
Pfizer:
St. Jude Medical:
Abbot Lab:
Amgen:
Astra Zeneca:
Bristol Myers Squibb:
Johnson and Johnson:
Shering-Plough:
Stryker:
Wyeth:
Zimmer Holdings:
Physician Payments Sunshine Act:
September 2007, Senators Grassley and Kohl introduce Physician Payments Sunshine Act:
May, 2008, after consultation with industry, the medical community, and other stakeholders, Physician Payments Sunshine Act is revised, expanded.
Side-by-Side, PPSA and existing state laws:
Industry support:
SAMPLE Endorsements:
AAMC:
Eli Lilly:
Advamed:
PhRMA:
Medtronic:
|
|
1:20 pm |
Implementation of Eli Lilly's Educational Grant Disclosure Program; Grant Funding Publishing Methodology: How to Publish; Lessons Learned: Pre and Post Publication Thoughts
Dave Garza, CPA, MBA
|
|
1:35 pm |
Review of Pfizer's Educational Grant Disclosure Program: Design and Implementation; Broader Disclosure Challenges Facing the Industry
Cathryn M. Clary, MD, MBA
|
|
1:50 pm |
Disclosure Issues Facing Device Companies; Lessons Learned from Recent Deferred Prosecution Agreements and Corporate Integrity Agreements; Potential Impact of The Physician Payments Sunshine Act
Vickie L. McCormick
|
2:05 pm |
Questions and Answers
John Kamp, JD, PhD (Moderator)
|
2:30 pm |
Audioconference Adjournment
|
|
|
|
|
